114 related articles for article (PubMed ID: 23987180)
1. Urinary proteome analysis in patients with stable SFU grade 4 ureteropelvic junction obstruction differs from normal.
Mesrobian HG; Kryger JV; Groth TW; Fiscus GE; Mirza SP
Urology; 2013 Sep; 82(3):745.e1-10. PubMed ID: 23987180
[TBL] [Abstract][Full Text] [Related]
2. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.
Mesrobian HG; Mitchell ME; See WA; Halligan BD; Carlson BE; Greene AS; Wakim BT
J Urol; 2010 Aug; 184(2):709-14. PubMed ID: 20639044
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
4. Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling.
Bandin F; Siwy J; Breuil B; Mischak H; Bascands JL; Decramer S; Schanstra JP
J Urol; 2012 Mar; 187(3):1006-11. PubMed ID: 22264461
[TBL] [Abstract][Full Text] [Related]
5. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
[TBL] [Abstract][Full Text] [Related]
6. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
Assadi F; Mazaheri M
J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
[TBL] [Abstract][Full Text] [Related]
7. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
Alizadeh F; Taefnia AM; Haghdani S
J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
[TBL] [Abstract][Full Text] [Related]
8. Urinary proteome analysis and the management of ureteropelvic junction obstruction.
Mesrobian HG
Pediatr Nephrol; 2010 Sep; 25(9):1595-6. PubMed ID: 20407913
[TBL] [Abstract][Full Text] [Related]
9. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY
Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
[TBL] [Abstract][Full Text] [Related]
10. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):213-9. PubMed ID: 22428472
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
[TBL] [Abstract][Full Text] [Related]
13. Factors indicating renal injury in pediatric bilateral ureteropelvic-junction obstruction.
Lee YS; Jeong HJ; Im YJ; Kim MJ; Lee MJ; Yun M; Han SW
Urology; 2013 Apr; 81(4):873-8. PubMed ID: 23395124
[TBL] [Abstract][Full Text] [Related]
14. Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.
Drube J; Zürbig P; Schiffer E; Lau E; Ure B; Glüer S; Kirschstein M; Pape L; Decramer S; Bascands JL; Schanstra JP; Mischak H; Ehrich JH
Pediatr Nephrol; 2010 Sep; 25(9):1673-8. PubMed ID: 20180135
[TBL] [Abstract][Full Text] [Related]
15. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.
Taranta-Janusz K; Wasilewska A; Dębek W; Fiłonowicz R; Michaluk-Skutnik J
Acta Paediatr; 2013 Sep; 102(9):e429-33. PubMed ID: 23772991
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction.
Chen H; Lin H; Xu M; Xu G; Fang X; He L; Chen Z; Wu Z; Geng H
Proteomics Clin Appl; 2019 Jul; 13(4):e1800101. PubMed ID: 30471240
[TBL] [Abstract][Full Text] [Related]
17. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up.
Chertin B; Pollack A; Koulikov D; Rabinowitz R; Hain D; Hadas-Halpren I; Farkas A
Eur Urol; 2006 Apr; 49(4):734-8. PubMed ID: 16504374
[TBL] [Abstract][Full Text] [Related]
18. Association between urinary biomarkers MMP-7/TIMP-2 and reduced renal function in children with ureteropelvic junction obstruction.
Wang HS; Cho PS; Zhi H; Kostel SA; DiMartino S; Dagher AM; Davis KH; Cabour LD; Shimmel A; Lee J; Froehlich JW; Zurakowski D; Moses MA; Lee RS
PLoS One; 2022; 17(7):e0270018. PubMed ID: 35834547
[TBL] [Abstract][Full Text] [Related]
19. Urine exoglycosidases are potential markers of renal tubular injury in children with ureteropelvic junction obstruction.
Taranta-Janusz K; Zalewska-Szajda B; Chojnowska S; Wasilewska A
Acta Paediatr; 2015 Nov; 104(11):e518-23. PubMed ID: 26095925
[TBL] [Abstract][Full Text] [Related]
20. The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study.
Mesrobian HG
World J Urol; 2009 Jun; 27(3):379-83. PubMed ID: 19034461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
